Uncover key drivers, emerging technologies, and competitive movements shaping the gene delivery technologies market from 2026–2035 with trusted insights from The Business Research Company
Across 2026–2030, what is the expected market valuation path of the Gene Delivery Technologies Market?
The gene delivery technologies market has seen rapid expansion in recent years. It is anticipated to increase from $4.29 billion in 2025 to $4.92 billion in 2026, at a compound annual growth rate (CAGR) of 14.7%. The growth observed in previous periods is attributable to factors such as increased gene therapy research, advancements in viral vectors, academic research funding, the adoption of electroporation techniques, and various vaccine development programs.
The gene delivery technologies market size is anticipated to undergo significant expansion over the next few years, set to reach $8.46 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.5%. This forecasted growth stems from factors such as the broadening of gene therapy pipelines, advancements in delivery vectors, an increased need for safer delivery methods, the expansion of cell therapy applications, and heightened clinical trial activity. Prominent trends expected during this period include a rise in the application of viral and non-viral delivery systems, greater integration into gene and cell therapy, the development of lipid nanoparticle technologies, a sharpened emphasis on targeted gene delivery, and improvements in physical gene transfer methods.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10706&type=smp
Which Drivers Are Supporting The Rise Of The Gene Delivery Technologies Market?
A rise in cell and gene therapies is anticipated to drive the expansion of the gene delivery technologies market in the future. These therapies are medical interventions designed to treat or ease diseases by modifying a patient’s genetic and cellular composition. The growing prevalence of cell and gene therapies primarily stems from progress in gene editing technologies, which are crucial for their development and market introduction. For example, IQVIA, a US-based firm offering advanced analytics, technology solutions, and contract research services, stated in March 2025 that new CAR T trial starts hit 199 in 2024, while gene therapy trial starts reached 130. These volumes represented increases of 54% and 65%, respectively. Consequently, the expansion of cell and gene therapies fuels the gene delivery technologies market.
What Segments Are Identified Within The Structure Of The Gene Delivery Technologies Market?
The gene delivery technologies market covered in this report is segmented –
1) By Mode: Biological, Chemical, Physical
2) By Method: Ex Vivo, In Vivo, In Vitro
3) By Application: Gene Therapy, Cell Therapy, Vaccines, Research
Subsegments:
1) By Biological: Viral Vectors, Bacterial Vectors, Lipid Nanoparticles
2) By Chemical: Cationic Lipids, Polymers, Chemical Transfection Agents
3) By Physical: Electroporation, Microinjection, Gene Gun, Sonoporation
Which Innovation Trends Are Advancing Developments Within The Gene Delivery Technologies Market?
Leading entities involved in gene delivery technologies prioritize the creation of sophisticated products, like ProteoAnalyzer, to secure a market advantage. ProteoAnalyzer, an advanced automated system, was developed by Agilent Technologies for conducting protein analysis, specifically employing parallel capillary electrophoresis (CE) technology. An example of this is the launch of the ProteoAnalyzer system by Agilent Technologies Inc., a US-based life sciences company, in July 2024. This cutting-edge platform is engineered for automated parallel capillary electrophoresis (CE), facilitating swift, high-resolution protein analysis using minimal sample volumes. This functionality proves especially valuable for researchers dealing with intricate protein mixtures across pharmaceuticals, biopharma, and bioengineered food ingredients, thereby accelerating discoveries and progress in translational research. The system’s capacity for in-depth scrutiny of protein mixtures is vital for the creation of therapeutic proteins.
Which Major Industry Participants Are Leading The Gene Delivery Technologies Market Growth?
Major companies operating in the gene delivery technologies market are Thermo Fisher Scientific Inc., QIAGEN NV, Horizon Discovery Group Co, OriGene Technologies Inc., Oxford Biomedica Solutions LLC, SignaGen Laboratories LLC, Vectalys SAS, Takara Bio Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, Promega Corporation, Catalent Inc., Pfizer Inc., Becton Dickinson and Company, Novartis AG, Intellia Therapeutics Inc., Editas Medicine Inc., CRISPR Therapeutics AG, Spark Therapeutics Inc., Bluebird Bio Inc., Sarepta Therapeutics Inc., Beam Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Moderna Inc., BioNTech SE, Translate Bio Inc., CureVac N.V., Lonza Group AG
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report
Which Geographic Areas Are Emerging As Strong Markets For The Gene Delivery Technologies Market?
North America was the largest region in the gene delivery technologies market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global gene delivery technologies market report during the forecast period. The regions covered in the gene delivery technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Gene Delivery Technologies Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=10706&type=smp
Browse Through More Reports Similar to the Global Gene Delivery Technologies Market 2026, By The Business Research Company
Advanced Drug Delivery Systems Market Report 2026
Recombinant Dna Technology Market Report 2026
https://www.thebusinessresearchcompany.com/report/recombinant-dna-technology-global-market-report
Genes Therapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model